Analysis of genetic and predisposing factors in Japanese patients with atypical hemolytic uremic syndrome.
about
Complement regulator CD46: genetic variants and disease associationsComplement therapy in atypical haemolytic uraemic syndrome (aHUS).Diagnostic criteria for atypical hemolytic uremic syndrome proposed by the Joint Committee of the Japanese Society of Nephrology and the Japan Pediatric Society.Analysis of patients with atypical hemolytic uremic syndrome treated at the Mie University Hospital: concentration of C3 p.I1157T mutation.Postoperative atypical hemolytic uremic syndrome associated with complement c3 mutation.Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome.The molecular and structural bases for the association of complement C3 mutations with atypical hemolytic uremic syndrome.A novel quantitative hemolytic assay coupled with restriction fragment length polymorphisms analysis enabled early diagnosis of atypical hemolytic uremic syndrome and identified unique predisposing mutations in Japan.Efficacy and safety of eculizumab in childhood atypical hemolytic uremic syndrome in Japan.Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohort.aHUS associated with C3 gene mutation: a case with numerous relapses and favorable 20-year outcome.Genetic variations in complement factors in patients with congenital thrombotic thrombocytopenic purpura with renal insufficiency.Prevention and treatment of atypical haemolytic uremic syndrome after kidney transplantation.No association between dysplasminogenemia with p.Ala620Thr mutation and atypical hemolytic uremic syndrome.Occurrence of atypical HUS associated with influenza B.Long-term Eculizumab Treatment Contributes to Recovery from End-stage Renal Disease Caused by Atypical Hemolytic Uremic SyndromeRare loss-of-function mutation in complement component C3 provides insight into molecular and pathophysiological determinants of complement activityWhere genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease.New functional and structural insights from updated mutational databases for complement factor H, Factor I, membrane cofactor protein and C3.Complement factor H R1210C among Japanese patients with age-related macular degeneration.A case of atypical hemolytic uremic syndrome associated with the c.1273C>T mutation in the complement C3 gene.Targeted exome sequencing in anti-factor H antibody negative HUS reveals multiple variations.Familial C3 glomerulonephritis associated with mutations in the gene for complement factor B.Clinical and renal biopsy findings predicting outcome in renal thrombotic microangiopathy: a large cohort study from a single institute in China.Atypical hemolytic uremic syndromeHemolytic uremic syndrome
P2860
Q28263110-39FB2536-DAD1-404E-911A-4A7938736797Q33408733-E7DB7854-EE3D-47CE-8413-6966E8086E70Q33412143-EF91916F-6229-488E-A014-960E304F81F8Q33417165-54A0F8C4-1DFE-4199-B1F6-4C2F591D8B14Q33418916-ECC5578F-D27A-4F42-96FC-73710224A8DEQ33419905-BAF507D6-C9F7-4BED-B5A9-FA7D1BDF1042Q33422057-D7A566AC-EE82-43E0-BF1A-67CA648C808CQ33422650-3DA9FAAD-3939-4895-9CB6-012540B800B9Q33424274-10357B9E-41E4-4D61-B727-EC598BBF20F6Q33424946-D8BBA16D-6E61-45EE-BEA5-70508CC525A1Q33427568-618124C3-7136-4405-84C1-A6E035129BC7Q33429667-2EFED409-2CB3-43A2-8E86-1A982058F855Q33430817-945B14D0-E0DB-4B91-B7A8-C6AD17CF5F92Q33432338-C55E2C96-AA41-4882-A9B5-3F244FEF10D9Q33438621-7C7524CB-B7DD-4D74-B8C0-31050E8B62F7Q33441517-CA501B29-BE7B-4844-9B69-55760EC74BB1Q35205450-960C6A70-5CF5-4C5A-802D-BE21936F6310Q37187461-69AAC2A2-48C7-48D3-8136-0646BDC8B7C0Q38304445-30F835F5-D2AF-4723-BA23-0F8D4157E8F8Q40691418-1A72FDBD-5896-432A-8523-2CD0D69DA354Q41359309-4E16E4D0-027E-4122-B286-C87B2F48675CQ47937936-297700E3-C75D-4756-9CAD-76D8F817F345Q50596770-7F9F50B8-6ED6-4498-B76E-6E723A3BAA2EQ51116023-E67C4A29-97A5-4F0E-AD76-9FA3498D3BF8Q56591965-948F828C-DE3F-4BE6-843B-F1E30F8A1A0CQ57701679-DB4B29F4-E08A-417E-9515-CCD98EE66B14
P2860
Analysis of genetic and predisposing factors in Japanese patients with atypical hemolytic uremic syndrome.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Analysis of genetic and predis ...... cal hemolytic uremic syndrome.
@ast
Analysis of genetic and predis ...... cal hemolytic uremic syndrome.
@en
type
label
Analysis of genetic and predis ...... cal hemolytic uremic syndrome.
@ast
Analysis of genetic and predis ...... cal hemolytic uremic syndrome.
@en
prefLabel
Analysis of genetic and predis ...... cal hemolytic uremic syndrome.
@ast
Analysis of genetic and predis ...... cal hemolytic uremic syndrome.
@en
P2093
P1433
P1476
Analysis of genetic and predis ...... cal hemolytic uremic syndrome.
@en
P2093
Akira Ashida
Eiji Ishikawa
Eiji Matsukuma
Fumihiko Nakamura
Hideo Wada
Hiroshi Harada
Hiroshi Yamada
Maiko Tomomori
Masanori Matsumoto
Masaomi Nangaku
P304
P356
10.1016/J.MOLIMM.2012.12.006
P577
2013-01-08T00:00:00Z